The Role of C-Reactive Protein in Atherosclerotic Cardiovascular Disease: An Overview

By  

Current Vascular Pharmacology, Vol. 6, Iss. 4, 2008-10 ,pp. : 258-270

Bentham Science Publishers

Access to resources Recommend Favorite

C-reactive protein level as a predictor of mortality in liver disease patients with bacteremia

By Janum Sine H.   Søvsø Morten   Gradel Kim O.   Schønheyder Henrik C.   Nielsen Henrik  

Scandinavian Journal of Gastroenterology, Vol. 46, Iss. 12, 2011-12 ,pp. : 1478-1483

Informa Healthcare

Access to resources Recommend Favorite

Increased Folate Intake with No Changes in Serum Homocysteine and Decreased Levels of C-Reactive Protein in Patients with Inflammatory Bowel Diseases

By Chiarello P.   Penaforte F.   Japur C.   Souza C.   Vannucchi H.   Troncon L.  

Digestive Diseases and Sciences, Vol. 54, Iss. 3, 2009-03 ,pp. : 627-633

Springer Publishing Company

Access to resources Recommend Favorite

Do associations with C-reactive protein and extent of coronary artery disease account for the increased cardiovascular risk of renal insufficiency

By Zebrack J.S.   Anderson J.L.   Beddhu S.   for the Intermountain Heart Collaborative Study Group.  

ACC Current Journal Review, Vol. 12, Iss. 5, 2003-09 ,pp. : 30-30

Elsevier

Access to resources Recommend Favorite

The effects of rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, on markers of endothelial cell activation, C-reactive protein, and fibrinogen levels in non-diabetic coronary artery disease patients

By Sidhu J.S.   Cowan D.   Kaski J.-C.  

Journal of the American College of Cardiology, Vol. 42, Iss. 10, 2003-11 ,pp. : 1757-1763

Elsevier

Access to resources Recommend Favorite